Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • anish_dattani_zoo
    Junior Member
    • Jan 2018
    • 1

    #1

    qPCR for determining ATAC-seq amplification cycles?

    Dear SeqAnswers,

    From my understanding of the Buenrostro et al ATAC-seq papers, they PCR amplify transposed DNA fragments with 5 PCR cycles (using custom Nextera primers). After this initial 5 cycles of PCR, they do a qPCR citing the following reaction:

    5 μl of previously PCR amplified DNA
    4.41 μl Nuclease Free H2O
    0.25 μl 25 μM Customized Nextera PCR Primer 1
    0.25 μl 25 μM Customized Nextera PCR Primer 2
    0.09 μl 100x SYBR Green I
    5 μl NEBNext High-Fidelity 2x PCR Master Mix

    1 cycle of 98°C for 30 sec
    20 cycles of 98°C for 10 sec, 63°C for 30 sec, 72°C for 1 min

    Then they plot linear Rn versus cycle and determine the cycle number that corresponds to ¼ of maximum fluorescent intensity.

    I have never done this sort of qpcr before. Am I right in thinking that they add ROX to calculate the RN valuE - the Sybr green intensity value divided by the ROX? So whatever cycle number comes out from the above calculation, we do that many cycles for the next PCR?

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...